Net Cash Fortress Stock Screen — Germany
A fortress balance sheet: more cash than debt, positive free cash flow and enough short-term assets to cover short-term bills one and a half times over. Companies like these can fund themselves through a downturn without asking banks or shareholders for money. The screen also asks for a return on equity of at least 8%.
The rules of this screen
A stock listed in Germany appears below only if it passes every rule:
- Return on equity (ROE) of at least 8%
- Net cash: more cash than total debt, with positive free cash flow
- Current ratio of at least 1.5 (short-term assets cover short-term liabilities 1.5 times)
- Market cap of at least €50 million
Data comes from company filings and market prices, refreshed after every trading day. Stocks with a missing value for any rule are left out.
Net Cash Fortress Stock Screen — Germany: top stocks by market cap
32 German stocks match this screen. Top 30 by market cap, data as of 13 Nov 2026.
| # | Company | Ticker | Sector | Mkt Cap | P/E | Div Yield | 1Y |
|---|---|---|---|---|---|---|---|
| 1 | Allianz SE | ALVXETRA | Financial Services | €178.5B | 15.4 | 3.69% | +32.9% |
| 2 | Talanx AG | TLXXETRA | Financial Services | €34.4B | 13.0 | 2.75% | +22.1% |
| 3 | Beiersdorf Aktiengesellschaft | BEIXETRA | Consumer Defensive | €18.4B | 19.6 | 1.19% | -9.1% |
| 4 | RATIONAL Aktiengesellschaft | RAAXETRA | Industrials | €7.1B | 26.4 | 2.54% | -4.4% |
| 5 | Fuchs SE | FPE3XETRA | Basic Materials | €5.8B | 16.0 | 2.83% | +11.9% |
| 6 | Fuchs SE | FPEXETRA | Basic Materials | €5.0B | 13.7 | 3.26% | +23.5% |
| 7 | DMG MORI AKTIENGESELLSCHAFT | GILXETRA | Industrials | €3.7B | — | 2.48% | +1.5% |
| 8 | AIXTRON SE | AIXAXETRA | Technology | €3.6B | 45.3 | 0.44% | +83.1% |
| 9 | BB Biotech AG | BBZAXETRA | Healthcare | €3.2B | — | — | +37.9% |
| 10 | Elmos Semiconductor SE | ELGXETRA | Technology | €2.0B | 16.9 | 1.31% | +25.8% |
| 11 | KSB SE & Co. KGaA | KSBXETRA | Industrials | €1.6B | 11.9 | 2.97% | -4.3% |
| 12 | KSB SE & Co. KGaA | KSB3XETRA | Industrials | €1.5B | 11.2 | 3.17% | -11.3% |
| 13 | Friedrich Vorwerk Group SE | VH2XETRA | Industrials | €1.5B | 13.6 | 0.97% | -18.7% |
| 14 | AlzChem Group AG | ACT0XETRA | Basic Materials | €1.4B | 22.6 | 1.46% | +5.1% |
| 15 | MLP SE | MLPXETRA | Financial Services | €1.3B | 18.7 | 3.08% | +89.1% |
| 16 | PFISTERER Holding SE | PFSEXETRA | Industrials | €1.2B | 17.8 | 1.28% | -12.1% |
| 17 | Shelly Group SE | SLYGXETRA | Industrials | €1.2B | 38.6 | 0.20% | +24.3% |
| 18 | Eckert & Ziegler SE | EUZXETRA | Healthcare | €959.9M | 18.7 | 1.58% | -0.4% |
| 19 | SUSS MicroTec SE | SMHNXETRA | Technology | €923.3M | 47.8 | 0.08% | +47.6% |
| 20 | Frequentis AG | FQTXETRA | Technology | €846.9M | 20.5 | 0.44% | -9.4% |
| 21 | Logwin AG | TGHNXETRA | Industrials | €817.7M | 14.7 | 4.41% | +20.8% |
| 22 | Einhell Germany AG | EINXETRA | Industrials | €743.9M | 10.0 | 2.88% | -19.4% |
| 23 | SNP Schneider-Neureither & Partner SE | SHFXETRA | Technology | €680.8M | 18.6 | 0.00% | +25.5% |
| 24 | IVU Traffic Technologies AG | IVUXETRA | Technology | €460.7M | 31.4 | 1.10% | +32.2% |
| 25 | M1 Kliniken AG | M12XETRA | Healthcare | €356.3M | 18.6 | 6.16% | +29.7% |
| 26 | MPC Oceanic Group AG | MPCGXETRA | Financial Services | €174.8M | 6.8 | 5.32% | +7.6% |
| 27 | Fabasoft AG | FAAXETRA | Technology | €174.7M | 13.9 | 3.03% | +7.5% |
| 28 | Aumann AG | AAGXETRA | Industrials | €164.7M | 13.6 | 8.22% | +7.1% |
| 29 | CeoTronics AG | CEKXETRA | Technology | €69.4M | 12.6 | 2.80% | -35.6% |
| 30 | Blue Cap AG | B7EXETRA | Financial Services | €65.9M | — | 4.41% | -25.8% |
The same rules on every market the screener covers: the US, Canada, Europe, Australia and more. Free, no account needed.
Run this screen on all 18,000+ stocksHow to use this screen
Cash can sit in a country it cannot easily leave, or belong to customers (deposits, prepayments). A big cash pile also lowers returns if management never uses it. Check where the cash is and what the company plans to do with it.
This page lists the stocks that pass a set of rules. It is not a recommendation to buy or sell any of them, and past results of a strategy say nothing certain about future returns.